Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preventive UDCA for PNAC in Preterm Infants
NCT05043194Unknown
- Start
- Jan 2021
- Primary completion
- Sep 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of ursodeoxycholic acid in cholestasis (2 arms). Primary endpoint: direct bilirubin value up to 10 weeks. Status: unknown.
02
Drugs
ursodeoxycholic acid
03
Conditions
cholestasis
Beyond the preview
Go deeper on NCT05043194.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05043194.